ask="2.25"
ask_size="1300"
average_daily_volume="90624"
bid="1.95"
bid_size="3500"
book_value="1.40"
change="-0.03"
change_from_200_day_moving_average="1.04"
change_from_50_day_moving_average="0.74"
change_from_52_week_high="-5.85"
change_From_52_week_low="0.06"
change_in_percent="-1.48%"
close="2.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="1824000"
high="2.10"
high_52_weeks="7.85"
last_trade_date="2/28/2017"
last_trade_price="2.00"
last_trade_size="100"
last_trade_time="3:58pm"
low="1.94"
low_52_weeks="1.94"
market_capitalization="5.36M"
moving_average_200_day="0.96"
moving_average_50_day="1.26"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.00"
open="2.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+108.73%"
percent_change_from_50_day_moving_average="+58.32%"
percent_change_from_52_week_high="-74.52%"
percent_change_from_52_week_low="+2.99%"
previous_close="2.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.45"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.12"
stock_exchange="NCM"
symbol="XTLB"
volume="89305"
weeks_range_52="1.94 - 7.85"
